Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by THOMPSON, J. A.
Right arrow Articles by GLASGOW, L. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by THOMPSON, J. A.
Right arrow Articles by GLASGOW, L. A.
NEUROLOGY 1975;25:94
© 1975 American Academy of Neurology

Multiple sclerosis and elevation of cerebrospinal fluid vaccinia virus antibody

JOEL A. THOMPSON, M.D., PATRICK F. BRAY, M.D. and LOWELL A. GLASGOW, M.D.

Departments of Neurology and Pediatrics, University of Utah Medical Center, Salt Lake City.

Thirty percent of 33 patients with a clinical diagnosis of multiple sclerosis and an elevation of cerebrospinal fluid (CSF) immunoglobulin G/albumin ratio greater than 2 standard deviations above the mean had elevation of the CSF vaccinia neutralizing antibody titer. Elevated titers were found in 1 of 23 patients with non-multiple sclerosis neurologic diseases and in none of the normal control patients. No linear correlation was found between the magnitude of the relative or absolute CSF immunoglobulin G concentration and the magnitude of the CSF vaccinia neutralizing antibody titers.

This study was supported in part by National Institutes of Health Training Grants 2 T1-NB 5503 and 2 T1-NB 5309, and by NINDS Special Fellowship 5 F11-NS-2447 NSRA.

An abstract of this paper was read before the twenty-sixth annual meeting of the American Academy of Neurology, April 27, 1974.

Received for publication July 2, 1974.

Dr. Thompson's address is Department of Neurology, University of Utah Medical Center, Salt Lake City, UT.




This article has been cited by other articles:


Home page
JAMAHome page
J. M. Adams
Measles and Vaccinia Antibodies in Multiple Sclerosis
JAMA, August 18, 1978; 240(7): 637 - 637.
[Abstract] [PDF]


Home page
Arch NeurolHome page
H. Miyamoto, J. E. Walker, A. H. Ginsberg, J. S. Burks, K. McIntosh, and C. H. Kempe
Antibodies to Vaccinia and Measles Viruses in Multiple Sclerosis Patients
Arch Neurol, June 1, 1976; 33(6): 414 - 417.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by AAN Enterprises, Inc.